185 related articles for article (PubMed ID: 36453607)
21. Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals.
Liu SC; Lai J; Huang JY; Cho CF; Lee PH; Lu MH; Yeh CC; Yu J; Lin WC
Cancer Imaging; 2021 Oct; 21(1):56. PubMed ID: 34627393
[TBL] [Abstract][Full Text] [Related]
22. Radiomics Based on Contrast-Enhanced CT for Recognizing c-Met-Positive Hepatocellular Carcinoma: a Noninvasive Approach to Predict the Outcome of Sorafenib Resistance.
Gu J; Bao S; Akemuhan R; Jia Z; Zhang Y; Huang C
Mol Imaging Biol; 2023 Dec; 25(6):1073-1083. PubMed ID: 37932610
[TBL] [Abstract][Full Text] [Related]
23. Multi-Region Radiomic Analysis Based on Multi-Sequence MRI Can Preoperatively Predict Microvascular Invasion in Hepatocellular Carcinoma.
Gao L; Xiong M; Chen X; Han Z; Yan C; Ye R; Zhou L; Li Y
Front Oncol; 2022; 12():818681. PubMed ID: 35574328
[TBL] [Abstract][Full Text] [Related]
24. Differentiating HCC from ICC and prediction of ICC grade based on MRI deep-radiomics: Using lesions and their extended regions.
Wang S; Wang X; Yin X; Lv X; Cai J
Phys Med; 2024 Apr; 120():103322. PubMed ID: 38452430
[TBL] [Abstract][Full Text] [Related]
25. Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma based on kupffer phase radiomics features of sonazoid contrast-enhanced ultrasound (SCEUS): A prospective study.
Dong Y; Zuo D; Qiu YJ; Cao JY; Wang HZ; Yu LY; Wang WP
Clin Hemorheol Microcirc; 2022; 81(1):97-107. PubMed ID: 35001883
[TBL] [Abstract][Full Text] [Related]
26. Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma.
Yang Y; Fan W; Gu T; Yu L; Chen H; Lv Y; Liu H; Wang G; Zhang D
Front Oncol; 2021; 11():756216. PubMed ID: 34692547
[TBL] [Abstract][Full Text] [Related]
27. Use of radiomics containing an effective peritumoral area to predict early recurrence of solitary hepatocellular carcinoma ≤5 cm in diameter.
Wang F; Cheng M; Du B; Li LM; Huang WP; Gao JB
Front Oncol; 2022; 12():1032115. PubMed ID: 36387096
[TBL] [Abstract][Full Text] [Related]
28. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
[TBL] [Abstract][Full Text] [Related]
29. Delta-radiomics models based on multi-phase contrast-enhanced magnetic resonance imaging can preoperatively predict glypican-3-positive hepatocellular carcinoma.
Han Z; Dai H; Chen X; Gao L; Chen X; Yan C; Ye R; Li Y
Front Physiol; 2023; 14():1138239. PubMed ID: 37601639
[No Abstract] [Full Text] [Related]
30. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
[TBL] [Abstract][Full Text] [Related]
31. A Deep Learning Workflow for Mass-Forming Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma Classification Based on MRI.
Liu Y; Wang B; Mo X; Tang K; He J; Hao J
Curr Oncol; 2022 Dec; 30(1):529-544. PubMed ID: 36661691
[TBL] [Abstract][Full Text] [Related]
32. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
[TBL] [Abstract][Full Text] [Related]
34. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
35. Preoperative Prediction of Pancreatic Neuroendocrine Neoplasms Grading Based on Enhanced Computed Tomography Imaging: Validation of Deep Learning with a Convolutional Neural Network.
Luo Y; Chen X; Chen J; Song C; Shen J; Xiao H; Chen M; Li ZP; Huang B; Feng ST
Neuroendocrinology; 2020; 110(5):338-350. PubMed ID: 31525737
[TBL] [Abstract][Full Text] [Related]
36. Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning.
Jiang YQ; Cao SE; Cao S; Chen JN; Wang GY; Shi WQ; Deng YN; Cheng N; Ma K; Zeng KN; Yan XJ; Yang HZ; Huan WJ; Tang WM; Zheng Y; Shao CK; Wang J; Yang Y; Chen GH
J Cancer Res Clin Oncol; 2021 Mar; 147(3):821-833. PubMed ID: 32852634
[TBL] [Abstract][Full Text] [Related]
37. Radiomics Based on Contrast-Enhanced MRI in Differentiation Between Fat-Poor Angiomyolipoma and Hepatocellular Carcinoma in Noncirrhotic Liver: A Multicenter Analysis.
Zhao X; Zhou Y; Zhang Y; Han L; Mao L; Yu Y; Li X; Zeng M; Wang M; Liu Z
Front Oncol; 2021; 11():744756. PubMed ID: 34722300
[TBL] [Abstract][Full Text] [Related]
38. LiverNet: efficient and robust deep learning model for automatic diagnosis of sub-types of liver hepatocellular carcinoma cancer from H&E stained liver histopathology images.
Aatresh AA; Alabhya K; Lal S; Kini J; Saxena PUP
Int J Comput Assist Radiol Surg; 2021 Sep; 16(9):1549-1563. PubMed ID: 34053009
[TBL] [Abstract][Full Text] [Related]
39. Multi-scale patches convolutional neural network predicting the histological grade of hepatocellular carcinoma.
Gu D; Guo D; Yuan C; Wei J; Wang Z; Zheng H; Tian J
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2584-2587. PubMed ID: 34891782
[TBL] [Abstract][Full Text] [Related]
40. Computed Tomography Radiomics-Based Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Yao W; Yang S; Ge Y; Fan W; Xiang L; Wan Y; Gu K; Zhao Y; Zha R; Bu J
Front Med (Lausanne); 2022; 9():819670. PubMed ID: 35402463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
